Issued Patents All Time
Showing 76–100 of 108 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9200277 | Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG | Joseph Collard | 2015-12-01 |
| 9173895 | Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1 | Joseph Collard | 2015-11-03 |
| 9163285 | Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP | Joseph Collard | 2015-10-20 |
| 9155754 | Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1 | Joseph Collard | 2015-10-13 |
| 9133456 | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene | Joseph Collard | 2015-09-15 |
| 9089588 | Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT) | Joseph Collard, Carlos Coito, Belinda De Leon | 2015-07-28 |
| 9074210 | Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF | Joseph Collard, Carlos Coito | 2015-07-07 |
| 9068183 | Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2 | Joseph Collard | 2015-06-30 |
| 9044493 | Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin | Joseph Collard | 2015-06-02 |
| 9044494 | Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21 | Joseph Collard | 2015-06-02 |
| 9023822 | Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP | Joseph Collard, Carlos Coito | 2015-05-05 |
| 9012139 | Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family | Joseph Collard | 2015-04-21 |
| 8993533 | Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4 | Joseph Collard | 2015-03-31 |
| 8987225 | Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG | Joseph Collard | 2015-03-24 |
| 8980857 | Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4 | Joseph Collard | 2015-03-17 |
| 8980858 | Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA | Joseph Collard | 2015-03-17 |
| 8980860 | Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG | Joseph Collard, Carlos Coito | 2015-03-17 |
| 8980856 | Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3 | Joseph Collard | 2015-03-17 |
| 8962586 | Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1 | Joseph Collard | 2015-02-24 |
| 8962585 | Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 | Joseph Collard | 2015-02-24 |
| 8957037 | Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor | Joseph Collard | 2015-02-17 |
| 8951981 | Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1 | Joseph Collard | 2015-02-10 |
| 8946182 | Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1 | Joseph Collard | 2015-02-03 |
| 8940708 | Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF | Joseph Collard | 2015-01-27 |
| 8921330 | Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene | Joseph Collard | 2014-12-30 |